文献速递泌尿生殖妇产影像MR

归一化表观扩散系数在鉴别交界性与恶性上皮性卵巢肿瘤中的价值

Value of normalized apparent diffusion coefficients in differentiating between borderline and malignant epithelial ovarian tumors.
PubMed 文献 · Eur J Radiol · 2019-06-26

本回顾性研究纳入53例交界性上皮性卵巢肿瘤(BEOTs)和148例恶性上皮性卵巢肿瘤(MEOTs),比较不同参考组织归一化表观扩散系数(nADC)与不同b值下ADC的鉴别诊断效能。结果显示无论b值如何,BEOTs的ADC肿瘤值和nADC均显著高于MEOTs;nADC尿液在全部nADC中诊断效能最佳,且与ADC肿瘤值无显著差异,并因不受b值影响而表现稳定。

要点

  • BEOTs的ADC肿瘤值和各参考组织nADC均显著高于MEOTs,可用于两者鉴别。
  • nADC尿液在全部nADC中诊断效能最佳,且与ADC肿瘤值无显著差异。
  • b值1000 s/mm²较800 s/mm²时ADC肿瘤值显著更低、诊断效能更高。

核心结论

  • ADC肿瘤值和nADC均能鉴别BEOTs与MEOTs;nADC尿液中表现最佳,且因不受b值影响而优于ADC肿瘤值。

研究设计与样本

  • 回顾性研究,纳入53例BEOTs和148例MEOTs,行常规磁共振及b值为800和1000 s/mm²的扩散加权成像,在肿瘤实性成分、臀大肌、髂腰肌和尿液中各测量ADC三次取平均值。

关键影像表现/征象

  • 无论b值如何,BEOTs的ADC肿瘤值和nADC均显著高于MEOTs。
  • b值1000 s/mm²时ADC肿瘤值显著低于800 s/mm²时。

诊断标准与关键数值

  • nADC尿液无论b值如何,诊断效能显著大于nADC臀大肌和nADC髂腰肌。
  • ADC肿瘤值与nADC尿液无论b值如何,诊断效能无显著差异。
  • b值1000 s/mm²时ADC肿瘤值的诊断效能大于800 s/mm²时。
  • nADC尿液在BEOTs或MEOTs中及不同b值间的诊断效能均无显著差异。

临床应用与阅片要点

  • 测量ADC时应关注b值选择:b值1000 s/mm²时ADC肿瘤值更低、诊断效能更高。
  • 以尿液为参考的nADC在不同b值下表现稳定,可作为鉴别BEOTs与MEOTs的参考指标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare the diagnostic performance of normalized apparent diffusion coefficients (nADCs) of different references with that of ADCs at differentb factors in differentiating borderline epithelial ovarian tumors (BEOTs) from malignant epithelial ovarian tumors (MEOTs).

METHOD: This retrospective study included 53 BEOTs and 148 MEOTs. Conventional magnetic resonance and diffusion-weighted imaging withb factors of 800 and 1000s/mm2 were performed. ADC was measured three times at solid components of tumors, gluteus maximus muscle (GMM), iliopsoas muscle (IM) and urine and then averaged. ADCtumor, nADCs were then obtained. Differences and the diagnostic performance of ADCtumor and nADCs between BEOTs and MEOTs with different b factors were compared.

RESULTS: ADCtumor, nADCs regardless of b factors were significantly higher in BEOTs than MEOTs. The diagnostic performance of nADCurine regardless of b factors was significantly larger than that of nADCGMM and nADCIM. There was no significant difference in the diagnostic performance between ADCtumor and nADCurine regardless of b factors. A significantly lower ADCtumor and a larger diagnostic performance for ADCtumor was found with a b factor of 1000s/mm2 than 800 s/mm2. There were no significant differences in nADCurine of BEOTs or MEOTs or in the diagnostic performance of nADCurine with b factors between 800 and 1000s/mm2.

CONCLUSIONS: ADCtumor and nADCs were both capable of differentiating BEOTs from MEOTs. nADCurine was the best of all nADCs and was superior to ADCtumor because of its stable performance in differentiating BEOTs from MEOTs, regardless of b factors.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Lu J, Pi S, Ma FH, et al. Value of normalized apparent diffusion coefficients in differentiating between borderline and malignant epithelial ovarian tumors. Eur J Radiol. 2019. PMID: 31439257. doi:10.1016/j.ejrad.2019.06.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。